News
The narrowed approval marks a shift from past recommendations for everyone ages 6 months and older to receive annual ...
The Food and Drug Administration (FDA) on Wednesday approved the updated version of Pfizer’s and Moderna’s COVID-19 vaccines ...
This year’s updated Covid-19 vaccines have been approved by the US Food and Drug Administration for adults 65 and older and younger people with certain medical conditions that put them at a higher ...
Novavax, Inc. (Nasdaq: NVAX) today announced that the U.S. Food and Drug Administration has approved the Nuvaxovid™ 2025-2026 ...
Unprecedented changes to federal vaccine policy have driven public health leaders in Michigan to set their own course for 2025 COVID-19 vaccines.
The U.S. Food and Drug Administration approved updated COVID-19 vaccines but for a more limited group: adults age 65 and ...
The Food and Drug Administration has approved the 2025-2026 formulation of Nuvaxovid (COVID-19 Vaccine, Adjuvanted).
In contrast, the American Academy of Pediatrics recently issued its own guidance based on its review of the evidence. The AAP recommends that all children 6 months to 23 months old and children 2 to ...
As the number of COVID-19 cases begin to increase, there have been shifts in the vaccine landscape, especially regarding updated COVID-19 shots. Through the week ending Aug. 23, 11.2% of the 37,732 ...
The CDC has stopped recommending COVID-19 vaccines for children and pregnant women, prompting disagreement from pediatricians ...
The state’s health department is issuing a COVID-19 vaccine health order. CVS and Walgreens are now requiring either a prescription for the COVID-19 vaccine or are not offering it at all in some ...
US FDA approves Novavax's Nuvaxovid 2025-2026 Formula Covid-19 vaccine: Gaithersburg, Maryland Friday, August 29, 2025, 11:00 Hrs [IST] Novavax, Inc. announced that the US Food an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results